Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 61 results found. Search for [ Nilesh Gupta ]

Results 1 to 21 of 61
PTI
August 7, 2019
Drug firm Lupin on Wednesday reported a 49.46 per cent rise in consolidated net profit to Rs 303.05 crore for the quarter ended June 30, 2019 on account of robust sales in India and overseas.


E Kumar Sharma
New Delhi, July 24, 2019
Analysts expect a better show in Q1 thanks to a combination of factors such as overall business improvement in the Unites States and a pick-up in demand in the domestic market.


PB Jayakumar
New Delhi, July 22, 2019
Zydus Cadila, India's fourth-largest drug company by revenue, is banking big on research of new drugs, even though others have bowed out. Zydus expects the new drug business to grow to Rs 3,500 crore in four-five years


BusinessToday.In
New Delhi, May 30, 2019
Swaraj, 66, who underwent a kidney transplant in December 2016, had decided to not contest the Lok Sabha elections due to health reasons


BusinessToday.In
New Delhi, May 15, 2019
Net profit after exceptional items was up 141.4 per cent at Rs 606.60 crore during the financial year ended March 31, 2019; sales for Q4 FY2019 were up 8.7 per cent at Rs 4,325.90 crore compared to Rs 3,978.50 crore in Q4 FY2018;


PTI
May 15, 2019



BusinessToday.In
April 12, 2019
Former Air Force chief NC Suri told India Today that he had not signed any such letter. In fact, Air Marshall Suri has written another letter to the President's office clarifying his stance. General SF Rodrigues said he had no idea about the letter and called it fake.


PTI
April 3, 2019



PTI
April 2, 2019



PTI
March 27, 2019



PTI
March 26, 2019



PTI
February 28, 2019



PTI
February 6, 2019



PTI
February 5, 2019



PTI
February 4, 2019



PTI
January 24, 2019



PTI
December 24, 2018



PTI
December 10, 2018



PTI
November 27, 2018



PB Jayakumar
New Delhi, November 26, 2018
Market changes and increased regulatory oversight in the US have hurt Lupin, but India's third-biggest drug maker is making efforts to come back.


PAGES 1 OF 4  1234